15–34 (n = 68) | 35–59 (n = 275) | ≥60 (n = 354) | Total (n = 697) | p-value | |
---|---|---|---|---|---|
Any drug resistance | 27 (39.7%) | 69 (25.1%) | 78 (22.0%) | 174 (25.0%) | 0.009 |
Resistant to | |||||
INH | 20 (29.4%) | 55 (20.0%) | 65 (18.4%) | 140 (20.1%) | 0.114 |
RIF | 22 (32.4%) | 47 (17.1%) | 26 (7.3%) | 95 (13.6%) | 0.000 |
Rfb | 10 (14.7%) | 31 (11.3%) | 13 (3.7%) | 54 (7.7%) | 0.000 |
EMB | 7 (10.3%) | 27 (9.8%) | 15 (4.2%) | 49 (7.0%) | 0.014 |
PZA | 5 (7.4%) | 21 (7.6%) | 9 (2.5%) | 35 (5.0%) | 0.010 |
Km | 2 (2.9%) | 9 (3.3%) | 2 (0.6%) | 13 (1.9%) | 0.036 |
Am | 2 (2.9%) | 6 (2.2%) | 2 (0.6%) | 10 (1.4%) | 0.131 |
Cm | 2 (2.9%) | 7 (2.5%) | 2 (0.6%) | 11 (1.6%) | 0.090 |
Sm | 5 (7.4%) | 15 (5.5%) | 17 (4.8%) | 37 (5.3%) | 0.685 |
Lfx | 7 (10.3%) | 10 (3.6%) | 12 (3.4%) | 29 (4.2%) | 0.028 |
Mfx | 7 (10.3%) | 8 (2.9%) | 11 (3.1%) | 26 (3.7%) | 0.011 |
Ofx | 7 (10.3%) | 9 (3.3%) | 12 (3.4%) | 28 (4.0%) | 0.021 |
Pto | 2 (2.9%) | 8 (2.9%) | 5 (1.4%) | 15 (2.2%) | 0.393 |
Cs | 1 (1.5%) | 2 (0.7%) | 1 (0.3%) | 4 (0.6%) | 0.450 |
PAS | 2 (2.9%) | 10 (3.6%) | 5 (1.4%) | 17 (2.4%) | 0.192 |
INH-monoresistance | 4 (5.9%) | 15 (5.5%) | 40 (11.3%) | 59 (8.5%) | 0.024 |
RIF-monoresistance | 6 (8.8%) | 7 (2.5%) | 1 (0.3%) | 14 (2.0%) | 0.000 |
Multidrug resistance | 16 (23.5%) | 40 (14.5%) | 25 (7.1%) | 81 (11.6%) | 0.000 |
Resistance to any FQsa | 7 (10.3%) | 11 (4.0%) | 12 (3.4%) | 30 (4.3%) | 0.035 |
Resistance to any SLIDsb | 2 (2.9%) | 10 (3.6%) | 2 (0.6%) | 14 (2.0%) | 0.021 |